Clinical Trial Update: Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating CAT-2003 in patients with dyslipidemia was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia
• Hypertriglyceridemia

Drugs mentioned

• CAT-2003

Snippet

Sponsor: Catabasis Pharmaceuticals | Conditions: Dyslipidemia, Hypercholesterolemia | Phase 2 | Status: COMPLETED